Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma

NCT01965353

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

NCT01723020

Conditions
Advanced Malignancy, Advanced Solid Tumors, Astrocytoma, +26 more
Locations
  • Research Site Santa Monica, California, United States
  • Research Site Norwalk, Connecticut, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Completed

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

NCT02045017

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
Locations
  • Krankenhaus der Elisabethinen Linz, I Interne Abteilung Linz, Austria
  • Medizinische Universitat Wien Vienna, Austria
  • Wilhelminenspital der Stadt Wien Vienna, Austria
  • Hopital Dypuytren-CHU de Limoges Limoges, France
View all 22 locations
View Trial Details

Related conditions